SANTANDREA, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.875
AS - Asia 1.722
EU - Europa 883
SA - Sud America 227
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 34
OC - Oceania 11
Totale 4.835
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.790
CN - Cina 510
SG - Singapore 428
IT - Italia 365
HK - Hong Kong 189
BR - Brasile 171
VN - Vietnam 171
GB - Regno Unito 112
BD - Bangladesh 88
KR - Corea 82
DE - Germania 76
RU - Federazione Russa 63
SE - Svezia 56
IN - India 52
CA - Canada 42
FR - Francia 42
ID - Indonesia 39
EG - Egitto 34
FI - Finlandia 32
NL - Olanda 28
MX - Messico 27
AR - Argentina 25
PK - Pakistan 25
IQ - Iraq 24
IR - Iran 23
ZA - Sudafrica 19
PL - Polonia 18
TR - Turchia 14
LT - Lituania 13
EC - Ecuador 12
UA - Ucraina 12
AU - Australia 11
JP - Giappone 11
PH - Filippine 11
CO - Colombia 10
ES - Italia 10
IL - Israele 9
AE - Emirati Arabi Uniti 7
AT - Austria 7
BE - Belgio 7
CH - Svizzera 7
NG - Nigeria 7
SA - Arabia Saudita 7
IE - Irlanda 6
MA - Marocco 6
MY - Malesia 6
JM - Giamaica 5
JO - Giordania 5
PT - Portogallo 5
BG - Bulgaria 4
DZ - Algeria 4
PY - Paraguay 4
RO - Romania 4
RS - Serbia 4
UZ - Uzbekistan 4
AM - Armenia 3
ET - Etiopia 3
HN - Honduras 3
PA - Panama 3
SN - Senegal 3
BF - Burkina Faso 2
GR - Grecia 2
HR - Croazia 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
OM - Oman 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.801
Salva come PNG Salva come JPEG
Città #
Ashburn 302
Santa Clara 287
Singapore 265
Hefei 227
Hong Kong 177
San Jose 163
Council Bluffs 107
Seoul 69
Ho Chi Minh City 60
Beijing 59
London 58
Los Angeles 57
New York 56
Milan 38
Chandler 35
Rome 30
Chicago 29
Hanoi 29
Buffalo 28
The Dalles 26
Helsinki 25
Cairo 23
Jakarta 23
Shanghai 23
São Paulo 23
Fairfield 21
Bologna 20
Lauterbourg 20
Nyköping 20
Kent 16
Munich 16
Schiffdorf 16
Warsaw 16
Dallas 15
Moscow 15
Orem 15
Johannesburg 14
Naples 14
Salt Lake City 11
Amsterdam 10
Bari 10
Da Nang 10
Florence 10
Mexico City 10
Modena 10
Montreal 10
Nuremberg 10
Toronto 10
Atlanta 9
Houston 9
Islamabad 9
Tokyo 9
Brembate di Sopra 8
Denver 8
Guayaquil 8
Phoenix 8
Rio de Janeiro 8
Turin 8
Wuhan 8
Baghdad 7
Boston 7
Cambridge 7
Catania 7
Haiphong 7
Istanbul 7
Miami 7
Seattle 7
Brooklyn 6
Charlotte 6
Dhaka 6
Dublin 6
Giza 6
Poplar 6
Portsmouth 6
Raleigh 6
Redondo Beach 6
Amman 5
Ann Arbor 5
Antwerp 5
Bagno a Ripoli 5
Belo Horizonte 5
Bengaluru 5
Campi Bisenzio 5
Kolkata 5
Kunming 5
Lagos 5
Lahore 5
Las Vegas 5
Manchester 5
Migliarino 5
Parma 5
San Diego 5
Turku 5
Austin 4
Belgrade 4
Boardman 4
Bremen 4
Chennai 4
Columbus 4
Düsseldorf 4
Totale 2.853
Salva come PNG Salva come JPEG
Nome #
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 590
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer 271
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 1: Focus on immunohistochemical results with discussion of pre-analytical and interpretation variables 254
Clinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center 250
How can we treat vulvar carcinoma in pregnancy? A systematic review of the literature 233
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 218
Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature 216
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. part 4: Experimental treatments in pre-clinical studies (cell lines and mouse models) 216
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 5: Epigenetic regulation of pd-l1 192
Biomarkers changes after neoadjuvant chemotherapy in breast cancer: A seven-year single institution experience 187
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 179
PRAME expression in cellular neurothekeoma: A study of 11 cases 174
Clinically unquestionable but histologically deceptive melanomas in acral skin grafts: PRAME confirms its role 166
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 161
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. Part 3: PD-L1, intracellular signaling pathways and tumor microenvironment 161
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 2: Clinic–pathologic correlations 157
Implementing an organoid platform to assess efficacy of PHD inhibitors as anti-cancer agents 155
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 150
Digital spatial profiling for pathologists 147
LncRNA TAZ-AS202 promotes lung cancer progression through the regulation of the E2F1 transcription factor 138
Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion 134
A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures 118
Harnessing the hypoxia pathway to set a new therapeutic strategy for KRAS-mutated lung adenocarcinoma 111
Characterization of EGLN1 as a pro-oncogenic factor and pharmacological target in lung cancer 101
null 83
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer 73
Totale 4.835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.255
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 0 0 0 2 6 3 8 2 2 8 7
2022/2023129 9 12 6 5 10 14 2 15 12 13 14 17
2023/2024442 17 17 30 40 53 40 61 42 18 48 38 38
2024/20251.233 18 41 45 100 215 175 115 65 147 53 118 141
2025/20262.517 221 157 221 295 332 94 291 113 271 215 209 98
2026/2027437 97 129 135 76 0 0 0 0 0 0 0 0
Totale 4.835